Skip to main content
Clinical Trials/CTRI/2020/03/024357
CTRI/2020/03/024357
Not yet recruiting
Phase 3

Homoeopathy as adjuvant therapy given along with standard medical management in Persons with Hemophilia and other bleeding disorders-A pragmatic cohort study

CCRH0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
CCRH
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
CCRH

Eligibility Criteria

Inclusion Criteria

  • 1\. PWH and diagnosed cases of other bleeding disorders of any age group beyond 04 years under standard medical management
  • 2\. PWH and other bleeding disorders willing to take adjuvant homoeopathic treatment for Haemophilia
  • 3\. Patients willing to sign written informed consent
  • 4\. Persons diagnosed with combinations of multi factor deficiencies

Exclusion Criteria

  • 1\. PWH or other bleeding disorders with a history of life\-threatening bleeds
  • 2\. Patients not willing to sign written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials